ROCHE FDA Approval NDA 013664

NDA 013664

ROCHE

FDA Drug Application

Application #013664

Application Sponsors

NDA 013664ROCHE

Marketing Status

Discontinued002

Application Products

002SUSPENSION;ORAL500MG/5ML0GANTANOLSULFAMETHOXAZOLE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1965-07-01STANDARD
LABELING; LabelingSUPPL18AP1978-01-05
LABELING; LabelingSUPPL19AP1997-01-09
LABELING; LabelingSUPPL20AP1997-01-09

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 13664
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"GANTANOL","activeIngredients":"SULFAMETHOXAZOLE","strength":"500MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GANTANOL","submission":"SULFAMETHOXAZOLE","actionType":"500MG\/5ML","submissionClassification":"SUSPENSION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.